4//SEC Filing
Kayitalire Louis 4
Accession 0001209191-21-063046
CIK 0001566373other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 9:34 PM ET
Size
6.6 KB
Accession
0001209191-21-063046
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-11-02$6.81/sh−39$266→ 54,280 total - Sale
Common Stock
2021-11-02$6.85/sh−25$171→ 54,255 total
Footnotes (2)
- [F1]Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
- [F2]Includes 45,443 restricted stock units.
Documents
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001831519
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 9:34 PM ET
- Size
- 6.6 KB